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Biochemical mechanisms of production of redox intermediates of redox-cycling drugs include: photo-
chemical events, either photoionization process or electron transfer from photoexcited states; electron
exchange of reduced form of a drug with the oxy state of oxygen-binding hemoproteins; oxidation by
catalytic metal centers (oxidases, peroxidases, oxygenases) of the reduced forms of drugs; or electron
transfer to the oxidized form ofadrugfrom activated intracellular electron transferchain (mitochondria,
microsomes, etc.).
Further reaction of these drug free radicals-can lead to oxidative damage by either direct attack of
biological macromolecules or via oxygen reduction, giving 2-, H202, and OH. The reaction pathway
depends on the presence of metal ions, natural scavengers, enzymes that control relative concentrations
of reactive species, and availability of oxygen in the environment.
Redox processes have been linked to pharmacological
effects ofdrugs since long time. Many drugs are redox
molecules, and in many instances oxidative damage
(lipid peroxidation, DNA cleavage, enzyme inactiva-
tion, etc.) is evident in tissues undergoing drug action.
The recent theory of"active" oxygen species as media-
tors ofoxidation damage is therefore pivotal to current
interpretation of the mechanism of action of several
drugs (1). The aim of the present article is to review
the biochemical factors of relevance to determine the
efficacy ofa foreign organic molecule (xenobiotic, drug)
to act through reversible redox cycling in a certain bi-
ologicalenvironment. Thebestcharacterized redox sys-
tems of this type include quinones and bipyridylium
cations, which give rise to semiquinoid structures and
nitroaromatic compounds, withtheirreductionproducts
up to the amine level. They give relatively stable free
radicals as one-electron redox intermediates according
to the one-electron equilibria (1)-(3).
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Redox enzymes, like oxidases, peroxidases, and oxy-
genases, have been shown to produce one-electron in-
termediates from drugs containing phenol, hydrazine,
thiol, polyhalogenalkyl, phenothazine and other groups
(2). Metal ions, which belong to the category ofredox-
cycling agents, will not be treated here unless strictly
associated to the action of organic drugs.
Primary Sources of Oxidative
Damage by Drugs
In this respect, four groups of sources can be distin-
guished which are likely to operate in vivo: physicalROTILIO ET AL.
agents, mononuclear oxygen-carriers (e.g., Hb, Mb),
metal centers ofcatalytical oxygen activation, and cel-
lular electron transport systems (e.g., respiratory
chains). In general, the primary event is a single-elec-
tron donation or abstraction process, giving rise to an
organic free radical.
Physical Agents
The light-sensitized action of drugs is a well known
occurrence in drug mechanisms. Often photodynamic
effects are related to a redox reaction with free radical
intermediates. The photochemical event usually in-
volves a photoionization, in which an electron is either
added to or ejected from a drug. In biological systems,
such reactions can occur under much milder conditions
than ordinary photochemistry, owing to the presence
ofsuitable light-sensitive electron donors and/or accep-
tors. Theenhancementbylightofthetripanocidalaction
ofcrystal violet (a triazylmethyl dye), is related to the
increased formation of the carbon-centered radical of
the drug (3) by photoreduction in the presence of re-
duced pyridine nucleotides. Photooxidation of pheno-
thiazines to cation free radicals is responsible, via sub-
sequent electron transfer to melanin, for the skin
pigmentation seen in patients undergoing chlorproma-
zine treatment (4).
On the other hand, visible light can excite anthra-
cycline quinone antibiotics, like Adriamycin and dau-
nomycin, to produce a direct electron transfer from the
excited state of the drug to oxygen and thus give rise
to"active"oxygenspecieswithouttheintermediate pro-
duction offree electrons (5).
Oxyhemoproteins
Many redox drugs react with oxyhemoglobin accord-
ing to the reaction (4):
HbO2 + RH + H+ -. MetHb + H202 + R- (4)
Phenols (6) and phenylhydrazines (7) are typical of
thismechanism. Thereactionleads to Hboxidation, but
it is actually a reduction ofthe bound oxygen in which
one electronisdonated tothe [HbFe(II)02]bythedrug
and another one by the iron; with H202, HbFe(III) and
the drug radical are products. The reactions involving
the resulting free radical, 02, and the other products,
HbFe(III) orH202, are sourcesoffurtheroxidizingspe-
cies. In particular, MetHb and H202 may behave as a
peroxidase-like system (see below), which has been in-
voked by other authors (8) as the real source ofphenyl-
hydrazine-derivedfreeradicals, accordingtoatwo-elec-
tron reduction of a ferryl (FeIV) form of oxy Hb.
Furthermore, quinones, like menadione (9) and Adria-
mycin (10) may actually oxidize [Hb Fe(II)02] to
HbFe(III) + 02 with resulting formation of semiqui-
nones. This is aparticular case ofamore general mech-
anism, which willbe treated below. These reactions are
likelytoberesponsible forthehemolyticeffectsofmany
drugs including also antimalarial 8-aminoquinoline (pri-
maquine) and sulfonamides. Thesedrugs arepotentially
hemolytic, especiallyinindividualswithglucose-6-phos-
phatedehydrogenase deficiencywhichimpairsthe H202
detoxifying power of the cell via GSH-dependent en-
zymes. Similar reactions with oxy Hb may occur in the
presence ofdivicine andisouramil, two aglycones which
are present in broad beans and may be responsible for
the hemolytic anemia (favism) affecting some glucose-
6-phosphate-deficient subjects (11). These compounds
are an aminophenol (divicine) and a hydroquinone (iso-
uramil) of pyrimidine structure and are likely to give
rise to semiquinoid form upon very facile autoxidation
(12), in a process apparently similar to the autoxidation
oftheir structural analog dialuric acid (13). It will be of
interest to investigate the influence of Hb on this au-
toxidation. In any case, oxidation of Hb occurs in red
cells treated with divicine, especially when the reduced
forms ofthe aglycones are continuously regenerated by
suitable electron donors like reduced glutathione or as-
corbate (14).
Catalytic Metal Centers
Metal impurities catalyze so-called "autoxidation" of
quinols, like neurotoxic substituted dopamines (13),
with formation ofdrug free radicals and superoxide or
hydrogen peroxide. Inthis context it should be recalled
that02 mayalsoreactwiththeoxidizedquinonicforms
of such compounds, like in the case of a-methyl-
dopa, giving rise to reactive semiquinones (15). Metal
centers of metalloenzymes are able to carry out reac-
tions with a number of drugs and in many cases a free
radical intermediate has been detected. Phenols (16),
aromatic amines (17), hydrazines (18), and thiols (19)
undergo one-electron oxidation in the presence of per-
oxidasesandH202. Xanthineoxidaseisabletousemany
drugs as single-electron acceptors from xanthine (20),
but the physiological significance of such reactions is
doubtful. Ceruloplasmin, afour-electron oxidase, isable
to oxidize many of its substrates with free radicals as
intermediates (21). Cytochrome P-450 (amono-oxygen-
ase) has been suggested to form free radicals during
microsomal oxidation ofpolycycic hydrocarbons and te-
trachloroalkanes, but definitive unambiguous evidence
for this process is still missing (2).
Electron Transfer Chains
This group encompasses the largest number ofcases.
Here are the oxidized forms of redox drugs to be re-
duced, usually to a free-radical intermediate, bybiolog-
ical electron donors, on the basis of suitable redox po-
tentials, enzyme specificity and often membrane
permeability, since most electron transfer chains are
membrane-bound. Therefore, if processes listed under
physical agents can be either reductions or oxidation of
a drug and those under oxyhemoproteins and catalytic
metal centers are oxidation, reactions of the electron
transfer type will be reduction ofthe drug and require
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anaerobiotic conditions tobe studied indetail. Quinones
like alloxan (22) and anthracyclines (23), nitroaromatic
compounds like nitrofurans (24) and nitroimidazoles
(25), bipyridyliums (26) are the best characterized sys-
tems which have been shown to produce free radicals
in the presence ofmitochondrial ormicrosomal electron
transfer chain and even whole cells or tissue homoge-
nates. It is established in nearly all such cases, that the
drug "intercalates" within the electron transfer chain
at a monoelectronic step, such as flavin or cytochrome,
then diverting electrons from physiological multielec-
tron reduction ofterminal acceptor to a single-electron
intermediate which uncouples the concerted electron
flux (23).
Further Reactions of Redox
Intermediates of Drugs: Biochemical
Mechanisms of Oxidative Damage
It is generally agreed that redox intermediates pro-
duced bybiological activation ofdrugs (mostly free rad-
icals) can undergo two types of reactions, potentially
leadingto damage ofbiomolecules. One type ofreaction
is direct attack of a macromolecule by an organic free
radical, usually leading to irreversible binding of the
drug to it. Another pathway is the reaction ofthe one-
ortwo-electron-reduced drug with oxygen, which leads
to production of02 and H202. These two "active" oxy-
gen species are capable of numerous reactions, espe-
cially in the presence of metal ions with eventual oxi-
dative damage of the target. Free OH radicals (27),
bound (or crypto) OH radicals (28), site-directed (by
selective metal coordination) OH radicals (29), and li-
poperoxides (30), have been suggested as suitable can-
didates forultimate oxidative step ofthe damaging pro-
cess. Aninterestingcase, whichisinawayintermediate
between the two primary reaction types, is direct re-
action ofadrug free radical with H202 to give OH (31).
It should be clear in this context that these alternate
pathways are somewhat mutually exclusive, as a func-
tion of the relative reaction rates under the particular
conditions where the radical is originated. A prefer-
ential reaction with 02 will prevent the radical from
direct attack to a biomolecule, and from this point of
view 02 may be considered as a free-radical scavenger.
Disproportionation of the radical itself to the fully re-
duced and fully oxidized forms or electron transfer to a
scavenger that gives rise to poorl,y reactive (toward
either oxygen or biomolecules) secondary free radicals
may be event of some relevance to eventual protection
ofbiological targets. Itisamatterofconcentrations and
rates, which direction the electron goes, and catalyst
availability (metal ions, enzymes) will determine which
intermediate will be more dangerous to the biological
environment.
Metal Ions
Besides being catalysts of autoxidation of reduced
drugs, metal ions have a critical role in the production
of the ultimate damaging species in many processes of
oxidative damage originating from redox activation of
drugs. It is established that OH' radical can be formed
from the interaction between 02 and H202 only in the
presence of redox metal ions (32). This process is re-
ferredtometal-catalyzed Haber-Weiss reactionand for-
mally is the sum of metal reduction by 02 and metal
reoxidation by H202 (Fenton reaction). A very similar
mechanism takes place when drug free radicals reduce
chelated Fe(III) directly, without the intervention of
02 (33). The actualrelevance ofsuch processes to cases
where redox cyclingofdrugs leads to production of02
andH202fromthereactionofreduced forms ofthedrug
with oxygen (again, possibly favored by metal ions),
depends on the kinetic suitability of the metal coordi-
nation for preferential reactions with 02, H202 and
drug free radicals (32,33). Also, the way of generation
ofdrug free radicals, e.g., either radiative or enzymatic
(34) seems to affect relative rate of reaction of free
radicals with metalions. Itis also well documented that
the Fenton reactionismuch more effective indamaging
macromolecules ifOH radicals are produced at the site
of damage (site-directed Fenton mechanism). This
mechanism is favored by site-specific chelation of the
metal (29). Mechanisms of this type have been shown
to be effective in the case of enzymes (35) DNA (36),
viruses (37) and bacteria (38), with ascorbate or para-
quat as oxy radical-forming drug.
Another type of site-directed, metal-mediated, oxi-
dativedamagebydrugsoccurswhenbindingofthedrug
itselfdirects the damage to specific sites (drug-directed
metal coordination). This has been shown in particular
in the case of DNA with bleomycin, Adriamycin and
their analogs as the best prototypes. The mechanism of
action of bleomycin, a glycopeptide-heterocyclic drug
that cleaves DNA, depends on two separate binding
properties of its structure, one capable to bind DNA
through intercalation of its bithiazole moiety, and an-
other one capable to bind Fe(II) and Fe(III) by several
of its nitrogenous groups (39). The ligated iron is the
site of redox activation of the drug, while the organic
moiety has no redox-active residue. First, if Fe(III) is
the starting oxidation state, it has to be reduced to
Fe(II), by thiols, NAD(P)H, ascorbate, etc. Then the
Fe(II) formbinds 02. Addition ofone more electron will
form "activated bleomycin" (B*) which, in the presence
of oxygen, is able to cleave DNA [Eq. (5)].
B Fe(II) B Fe(II) 02
e ~ e
B Fe(III)
in
B* DNA
120 2i. cleavage
(5)
Alternatively, activated bleomycin may be formed
from reaction of Fe(III) bleomycin with peroxide. Al-
though no definitive evidence for the ultimate oxidizing
species has been presented, the process is analogous
with formation of oxidizing complexes of drugs with
oxyhemoglobin and peroxidase/H202. Also, anthracy-
cline antibiotics are Fe(III)-chelators, and the resulting
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chelate binds to DNA, in a way that is apparently dif-
ferent from that of drug intercalation (40). The DNA-
bound complex is able to mediate reduction of oxygen
by external reductants, like thiols, and to cleave DNA
in a process requiring peroxide. Again, a target-di-
rected production of OH radical by Fenton chemistry
is the most likely explanation of the process, although
ferryl-ion species, like in peroxidases, can be produced
viaaniron-peroxointermediate. Eitherpathway should
account for those cases where OH radical scavengers
prove to be less effective because free OH is not in-
volved. These cases are analogous to those referred to
as "crypto-OH" radicals (28).
It should be noted that quinones like Adriamycin,
have a dual potential ofredox cycling, i.e. viametal ion
redox shuttle or via quinone-hydroquinone redox shut-
tle. The former case may be operative with either the
quinone or the hydroquinone form of the drug as the
metal-chelator, the hydroquinone being also capable of
reducing it. The latter case requires either the hydro-
quinone or the semiquinone form to react with oxygen.
However, in the semiquinone-mediated cases, the drug
has to be free, and therefore the oxidation species will
be produced distantly from the DNA target. In fact, in
this case OH scavengers are effective protectors
against DNA cleavage (27).
In conclusion, availability ofredox metal ions for co-
ordination bytarget-specific drugs, seemsto favordrug
toxicity, regardless of intrinsic capability of redox cy-
cling by the drug itself, in addition to the role of free
metal impurities in catalyzing OH radical formation
from 02 and H202 produced by redox-cycling drugs.
Natural Scavengers of Reactive Redox
Intermediates (Natural Noncatalytic
Antioxidants)
It is widely accepted that the antioxidant properties
of, for example, carotenoids (precursors of vitamin A)
tocopherols (vitamin E), and ascorbate (vitamin C) are
related to their ability to scavenge free radicals. In any
case, the vitamin free radical will be formed, and the
protective efficacy of the vitamin actually depends on
further reactions of such a radical. In particular, it is
established that in aqueous solution containing metal
impurities, ascorbic acid produces °2 via its free rad-
ical (41) and this makes it rather a pro-oxidant com-
pound. However it has been reported that the vitamin
C free radical can be reduced back to vitamin C by a
NADH-dependent system (42). In other cases, dispro-
portionationofthescavengerfreeradicalsmaybefaster
than potentially noxious reaction with oxygen or biom-
olecules.
Among natural antioxidants, the plant pigments of
flavonoid nature (e.g., quercetin) appears to be partic-
ularly interesting in view ofpossible protection against
redoxcyclingdrug. Inourlaboratory, evidencehasbeen
obtained that such compounds diminish the oxygen con-
sumption and inhibit the formation of the EPR signal
oftheparaquatandanthracycline freeradicalsproduced
by NADPH addition to rat liver microsomes. This re-
action appears to prevent OH' radical formation from
H202 and the drug free radical (43). Inhibition of the
anthracycline-augmented oxygen uptake in microsomal
incubations has been also found with vitamin E (44).
Therefore, a similar mechanism seems to apply for the
protective effects of some natural antioxidants against
redox cycling drugs, which apparently is lowering the
concentration of drug-derived species particularly re-
active toward oxygen.
Enzymes That Control Noxious Reactions
of Redox Intermediates of Drug Action
A potentially defensive role may coexist with poten-
tial source of damage in the mechanism of various
classes ofenzymes. Thus oxidases, oxygenases and per-
oxidasesmaywellproducereactive intermediates when
actingondrugs, buttheywillreduce dioxygentowater,
thus decreasing the steady state level of intermediate
reduction products of oxygen. An enzyme capable of
reducing the vitamin C radical to vitamin C has been
already mentioned (42). Production of free-radical in-
termediates from microsomal or mitochondrial activa-
tion ofquinones or nitroaromatics can be prevented by
the two-electron reduction, forming hydroquinones or
nitroso compounds directly, which is catalyzed by DT-
diaphorase (45). This reaction may serve a protective
function, since hydroquinones and nitroso compounds
are less reactive than semiquinones and nitro anion rad-
icals, and hydroquinones are more easily excreted by
the cellthan semiquinones. The enzymes that are active
on 02 and H202 are considered to be of primary im-
portance in this respect. It should be kept in mind that
their functions appear to be complementary to each
other. In fact, a proper balance between superoxide
dismutase and the H202-removing enzymes (primarily
glutathione peroxidase, catalase being localized inside
peroxisomes in most cells) seems to be essential with
regardto both modality andintensity of"active oxygen"
production. Since redox-cycling drugs mostly work
through the univalent oxygen reduction pathway, lead-
ing to H202 via superoxide dismutation, enzyme catal-
ysis of this reaction has to be matched with adequate
enzymic control ofH202. Many natural situations point
to actual relevance of such an aspect, in particular to
efficacy of redox drugs on targets with a selectively
unbalanced [superoxide dismutase]/[GSH-peroxidase
(±catalase)] ratio. Antimalarial drugs activated
through the oxyhemoglobin mechanism may destroy
plasmodial cells because oftheir deficiency in H202-re-
moving enzymes (46). The same argument seems to ap-
ply to trypanocidal drugs versus trypanosomes (47), al-
loxan injury to pancreatic islets (48), tumor killing by
anthracyclines (49), drug-induced hemolysis (50), brain
sensitivity to oxygen-mediated damage (51), and heart
sensitivity to Adriamycin therapy (52). In this respect,
a suitable experimental model has been obtained by
treating rats with hypolipidemic drugs ofthe clofibrate
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family (53). Thistreatment leadstodecreaseofenzymes
acting on oxy radicals in liver. This effect is associated
with an increased susceptibility of the tissue to en-
hanced peroxidative risk only in those samples where
GSH peroxidase is much more decreased than super-
oxide dismutase with respect to normal controls.
Hypoxia and Redox-Cycling Drugs
It has been already mentioned that there are two
generally accepted theories ofcell sensitivity to redox-
cycling drugs, focusing on either direct attack of cell
components byreactive redoxintermediatesofthe drug
itself(organic free radicals), or formation ofoxygen re-
active species like O2, H202, and OH'. It has also been
said that the two hypotheses can not coexist, because
the latter requires oxygen, while the former requires
lack ofoxygen. Hypoxic "oxidative" damage by redox-
cycling drugs may therefore be conveniently explained
in terms of direct reactions of organic free radicals,
although many authors emphasize the role of the re-
perfusion-reoxygenation step in determining a "burst"
of oxygen reduction by organic free radicals accumu-
lated during the hypoxic phase. This is not a trivial
difference, since prevention and management of side
effects ofdrugtherapy inhypoxic conditions iscritically
dependent on which mechanism is operating. In fact,
antioxygenic enzymes will not be effective in protection
against direct damage by organic free radical, while
they may be taken in consideration if the reperfusion
mechanism is the major cause ofinjury to ischemic tis-
sues. On the other hand "scavengers" like vitamins A,
E, and Chave suchreactionproperties astobeeffective
in protecting ischemic tissues against purely anoxic
free-radical pathways of drug metabolism.
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